The Individual Participant Data Integrity Tool for assessing the integrity of randomised trials
Research Synthesis Methods · 2024-11 · 15 (6) · 917-939
DOI: 10.1002/jrsm.1738 ↗Kurz gefasst
Fachartikel in der Zeitschrift Research Synthesis Methods, online erschienen am 13.08.2024. Verfasst von Kylie E Hunter und 12 weiteren Autor:innen. Beteiligte Einrichtung: NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Randomized Controlled Trials as Topic, Research Design. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Increasing concerns about the trustworthiness of research have prompted calls to scrutinise studies' Individual Participant Data (IPD), but guidance on how to do this was lacking. To address this, we developed the IPD Integrity Tool to screen randomised controlled trials (RCTs) for integrity issues. Development of the tool involved a literature review, consultation with an expert advisory group, piloting on two IPD meta‐analyses (including 73 trials with IPD), preliminary validation on 13 datasets with and without known integrity issues, and evaluation to inform iterative refinements. The IPD Integrity Tool comprises 31 items (13 study‐level, 18 IPD‐specific). IPD‐specific items are automated where possible, and are grouped into eight domains, including unusual data patterns, baseline characteristics, correlations, date violations, patterns of allocation, internal and external inconsistencies, and plausibility of data. Users rate each item as having either no issues, some/minor issue(s), or many/major issue(s) according to decision rules, and justification for each rating is recorded. Overall, the tool guides decision‐making by determining whether a trial has no concerns, some concerns requiring further information, or major concerns warranting exclusion from evidence synthesis or publication. In our preliminary validation checks, the tool accurately identified all five studies with known integrity issues. The IPD Integrity Tool enables users to assess the integrity of RCTs via examination of IPD. The tool may be applied by evidence synthesists, editors and others to determine whether an RCT should be considered sufficiently trustworthy to contribute to the evidence base that informs policy and practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.
- Department of Obstetrics and Gynaecology, Monash University, Clayton, Victoria, Australia.
ORCID-Profile: Kylie E Hunter, Rui Wang
Zitieren
APA
Hunter, K. E., Aberoumand, M., Libesman, S., Sotiropoulos, J. X., Williams, J. G., Aagerup, J., Wang, R., Mol, B. W., Li, W., Barba, A., Shrestha, N., Webster, A. C., & Seidler, A. L. (2024). The Individual Participant Data Integrity Tool for assessing the integrity of randomised trials. Research Synthesis Methods, 15(6), 917-939. https://doi.org/10.1002/jrsm.1738
Vancouver
Hunter KE, Aberoumand M, Libesman S, Sotiropoulos JX, Williams JG, Aagerup J, et al. The Individual Participant Data Integrity Tool for assessing the integrity of randomised trials. Research Synthesis Methods. 2024;15(6):917-939. doi:10.1002/jrsm.1738
BibTeX
@article{Hunter2024,
author = {Hunter, Kylie E and Aberoumand, Mason and Libesman, Sol and Sotiropoulos, James X and Williams, Jonathan G and Aagerup, Jannik and Wang, Rui and Mol, Ben W and Li, Wentao and Barba, Angie and Shrestha, Nipun and Webster, Angela C and Seidler, Anna Lene},
title = {The Individual Participant Data Integrity Tool for assessing the integrity of randomised trials},
journal = {Research Synthesis Methods},
year = {2024},
volume = {15},
number = {6},
pages = {917--939},
doi = {10.1002/jrsm.1738}
}
EUVIMED